The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 338:1696-1698 June 4, 1998 Number 23
NextNext

Conflict of Interest in the Debate over Calcium-Channel Antagonists

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Stelfox, H. T.
-PubMed Citation
To the Editor: The article by Stelfox et al. (Jan. 8 issue)1 is ambiguous and undermined by a self-fulfilling prophecy. The authors concluded that there is no evidence of conflict of interest but not before compiling confusing information to the contrary.

Supporters and critics of calcium-channel antagonists were questioned about five types of financial relationships as though they were independent variables. However, three of these relationships — "support to attend symposium," "honorarium to speak at symposium," and "support for educational program" — are often found together. Simply receiving such support is equated with financial conflict of interest without any attempt . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.